Lipocine $LPCN 4th Submission Run-up

Lipocine Inc LPCN has a PDUFA on Aug. 28 for Tlando, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men.

Lipocine Announces Derivative Suit Was Dismissed 7/31/2020
prnewswire.com/news-releases/lipocine-announces-derivative-suit-was-dismissed-301103629.html

I really like how this chart is setting up over the $1.60 level if volume continues. There is a lot of short squeeze potential in the name, and always manage your risk.